Oncology Molecular Diagnostics Market to Hit USD 6.46 Billion by 2033, Industry Growth, Key Insights & Outlook

Global Oncology Molecular Diagnostics Market Trends & Outlook 2025–2033 | USD 6.46 Billion by 2033

AUSTIN, TX, UNITED STATES, October 29, 2025 /EINPresswire.com/ -- Overview of the Market:

The global oncology molecular diagnostics market is centered on advanced laboratory techniques and platforms used to detect and monitor cancer at the molecular level. These diagnostics include methods such as polymerase chain reaction (PCR), next-generation sequencing (NGS), in situ hybridization (ISH), liquid biopsy, and companion diagnostic assays that guide targeted therapies.

Market Size and Forecast:

According to DataM Intelligence, the oncology molecular diagnostics market size reached approximately US$ 3.79 billion in 2024, up from about US$ 3.59 billion in 2023, and is projected to grow to around US$ 6.46 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 6.2% for the period 2025-2033. This growth is underpinned by rising global cancer incidence, increasing adoption of precision medicine and companion diagnostics, and rapid innovation in molecular testing technologies.

𝗚𝗲𝘁 𝗮 𝗦𝗮𝗺𝗽𝗹𝗲 𝗣𝗗𝗙 𝗕𝗿𝗼𝗰𝗵𝘂𝗿𝗲 𝗼𝗳 𝘁𝗵𝗲 𝗥𝗲𝗽𝗼𝗿𝘁 (𝗨𝘀𝗲 𝗖𝗼𝗿𝗽𝗼𝗿𝗮𝘁𝗲 𝗘𝗺𝗮𝗶𝗹 𝗜𝗗 𝗳𝗼𝗿 𝗮 𝗤𝘂𝗶𝗰𝗸 𝗥𝗲𝘀𝗽𝗼𝗻𝘀𝗲): https://www.datamintelligence.com/download-sample/oncology-molecular-diagnostics-market

Recent Developments:

USA:

October 2025: U.S. oncology molecular diagnostics market saw FDA approvals for expanded liquid biopsy panels allowing earlier and non-invasive detection of multiple cancer types, enabling wider use in routine screening and monitoring.

September 2025: Leading U.S. labs launched AI-driven algorithms for mutation analysis and clinical decision support, facilitating faster and more accurate genomic profiling for personalized cancer treatment.

Japan:
September 2025: Japanese diagnostics companies accelerated collaborations with hospital networks to deploy multiplex PCR and NGS panels for solid tumors, supporting broader access to precision oncology across regional healthcare centers.

August 2025: New reimbursement policies were implemented by Japanese authorities to include molecular diagnostic tests for breast, lung, and colorectal cancer in public insurance, promoting adoption and market growth.

Key Market Highlights:

➣ North America dominated the oncology molecular diagnostics market in 2024, accounting for the largest revenue share of 44.27%. The Asia Pacific region emerged as the fastest-growing market, projected to register the highest CAGR of 6.7% during the forecast period.

➣ By technology, the Polymerase Chain Reaction (PCR) segment led the market with a dominant revenue share of 52.12% in 2024.

➣ Key players in the oncology molecular diagnostics market include Abbott, QIAGEN, F. Hoffmann-La Roche Ltd, BD, Cepheid, Hologic, Inc., Sysmex Corporation, Bio-Rad Laboratories, Inc., Foundation Medicine, Inc., and ASURAGEN, INC., among others.

Market Segmentation:

The oncology molecular diagnostics market segmentation spans multiple dimensions including product type, technology, application (cancer type), end-user, and geography.

➥ By Product Type: Reagents, Instruments, Software

➥ By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), In Situ Hybridization (ISH), Others

➥ By Application: Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, Others

➥ By End-User: Hospitals, Clinical Laboratories, Others

By Region: The geographic segmentation covers North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Each region presents distinct growth dynamics influenced by factors such as healthcare spending, reimbursement mechanisms, regulatory environment, disease burden and infrastructure development.

Looking For A Detailed Full Report? Get it here: https://www.datamintelligence.com/buy-now-page?report=oncology-molecular-diagnostics-market

Regional Insights:

North America is projected to lead the global oncology molecular diagnostics market, accounting for approximately 44.27% of the market share in 2024.
Europe’s oncology molecular diagnostics market is experiencing strong growth, fueled by the rising cancer burden, technological innovation, and supportive healthcare initiatives. The growing incidence of cancers such as breast, lung, and colorectal remains a major driver, with the EU projected to record approximately 1.27 million cancer-related deaths in 2024 and age-standardized mortality rates of 123.2 per 100,000 men and 79.0 per 100,000 women.

Asia Pacific is the fastest-growing region in the global oncology molecular diagnostics market, registering a CAGR of 6.7% in 2024. Rising incidence of cancer (driven by demographic changes and lifestyle factors), growing healthcare infrastructure, medical tourism expansion, and increased government and private spending in diagnostics have created fertile ground for molecular diagnostics. Countries like China, India, Japan and South Korea are particularly active in deploying genomic diagnostics, liquid biopsy and companion diagnostics. Challenges such as cost, reimbursement and regulatory harmonization remain but are gradually being addressed.

Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/oncology-molecular-diagnostics-market

Key players:

• Abbott Laboratories
• QIAGEN N.V.
• F. Hoffmann-La Roche Ltd
• BD (Becton, Dickinson and Company)
• Cepheid (Danaher Corporation)
• Hologic, Inc.
• Sysmex Corporation
• Bio-Rad Laboratories, Inc.
• Foundation Medicine, Inc.
• ASURAGEN, Inc.

Reasons to Buy the Report:

✔ Obtain comprehensive insights into the oncology molecular diagnostics market size, trends, forecasts, and competitive landscape.
✔ Gain detailed market segmentation by product type, technology, application (cancer type), end-user, and geography to support strategic decisions.
✔ Understand key market drivers, restraints and opportunities to better position technologies and investments in molecular diagnostics.
✔ Benchmark leading industry players, assess recent developments, collaborations, product launches and validate market share dynamics.
✔ Access region-specific intelligence and market data (e.g., North America, Europe, Asia-Pacific, Latin America, Middle East & Africa) for targeted growth strategies.

Conclusion:
In summary, the oncology molecular diagnostics market is undergoing significant transformation, driven by aging populations, rising cancer incidence, the imperative for precision oncology, and rapid technological advancements in molecular testing. With a market size projected to grow from around US$ 3.79 billion in 2024 to approximately US$ 6.46 billion by 2033, the trajectory is clearly upward. While the PCR segment currently commands the largest share, emerging technologies such as NGS, liquid biopsy and AI-driven analytics will shape the future landscape. North America remains the dominant region today, but Asia-Pacific and other emerging regions present the strongest growth potential.

Frequently Asked Questions (FAQs):

Q: How big is the global oncology molecular diagnostics market?
Ans: The global oncology molecular diagnostics market is expected to reach growth at a 6.2% CAGR.

Q: What is the projected growth rate (CAGR) of the oncology molecular diagnostics market between 2025 and 2033?
Ans: The global oncology molecular diagnostics market is valued at US$3.79 Billion in 2024 and is projected to reach US$6.46 Billion by 2033.

Q:Which region is expected to dominate the oncology molecular diagnostics industry through the forecast period?
Ans: North America dominated the oncology molecular diagnostics market in 2024, accounting for the largest revenue share of 44.27%.

Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Competitive Landscape:

Sustainability Impact Analysis
KOL / Stakeholder Insights
Unmet Needs & Positioning, Pricing & Market Access Snapshots
Market Volatility & Emerging Risks Analysis
Quarterly Industry Report Updated
Live Market & Pricing Trends
Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Related Topics:

Molecular Diagnostics Market Share

POC Molecular Diagnostics Market Size

Sai Kiran
DataM Intelligence 4Market Research
+1 877-441-4866
email us here
Visit us on social media:
LinkedIn
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.